Clinical trial

Insulin Versus Oral Hypoglycemic Agents in Gestational Diabetes Mellitus

NCT07582471

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2025-10-08

PhaseNA

Study timeline

Study start (actual)2025-10-08Date precision: day

Registry last updated2026-05-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Gestational Diabetes Mellitus (GDM)unresolved

Interventions

Insulin (Humulin® R U-100)DRUG

Oral Hypoglycemic Agents,OralDRUG

Sponsors & collaborators

Dr Mudassar Saeed Pansotalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07582471 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.